A Schuchat

Summary

Affiliation: Centers for Disease Control and Prevention
Country: USA

Publications

  1. ncbi Monitoring the impact of vaccines postlicensure: new challenges, new opportunities
    Anne Schuchat
    National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Mailstop E 05, Atlanta, GA 30333, USA
    Expert Rev Vaccines 7:437-56. 2008
  2. ncbi Reflections on pandemics, past and present
    Anne Schuchat
    National Center for Immunization and Respiratory Disease, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
    Am J Obstet Gynecol 204:S4-6. 2011
  3. ncbi Active bacterial core surveillance of the emerging infections program network
    A Schuchat
    Centers for Disease Control and Prevention, Mailstop C23, 1600 Clifton Rd, Atlanta, GA 30333, USA
    Emerg Infect Dis 7:92-9. 2001
  4. ncbi Pneumonia in children in the developing world: new challenges, new solutions
    Anne Schuchat
    Respiratory Diseases Branch, Division of Bacterial and Mycotic Diseases, National Center for Infectious Diseases, Centers for Disease Control and Prevention, 1600 Clifton Road NE, Atlanta, GA 30333, USA
    Semin Pediatr Infect Dis 15:181-9. 2004
  5. ncbi The science behind preparing and responding to pandemic influenza: the lessons and limits of science
    Anne Schuchat
    Centers for Disease Control and Prevention, Atlanta, Georgia, USA
    Clin Infect Dis 52:S8-12. 2011
  6. ncbi Inhalational anthrax outbreak among postal workers, Washington, D.C., 2001
    Puneet K Dewan
    Centers for Desease Control and Prevention, Atlanta, Georgia 30333, USA
    Emerg Infect Dis 8:1066-72. 2002
  7. ncbi The changing epidemiology of meningococcal disease in the United States, 1992-1996
    N E Rosenstein
    Division of Bacterial Diseases, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
    J Infect Dis 180:1894-901. 1999
  8. ncbi Evaluation of universal antenatal screening for group B streptococcus
    Melissa K Van Dyke
    Epidemic Intelligence Service Program, Office of Workforce and Career Development, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
    N Engl J Med 360:2626-36. 2009
  9. ncbi Cryptococcosis: population-based multistate active surveillance and risk factors in human immunodeficiency virus-infected persons. Cryptococcal Active Surveillance Group
    R A Hajjeh
    Centers for Disease Control and Prevention, Mycotic Diseases Branch, Division of Bacterial and Mycotic Diseases, Atlanta, GA 30333, USA
    J Infect Dis 179:449-54. 1999
  10. ncbi Incidence of macrolide resistance in Streptococcus pneumoniae after introduction of the pneumococcal conjugate vaccine: population-based assessment
    David S Stephens
    Department of Medicine, Emory University School of Medicine, Atlanta, GA, USA
    Lancet 365:855-63. 2005

Detail Information

Publications94

  1. ncbi Monitoring the impact of vaccines postlicensure: new challenges, new opportunities
    Anne Schuchat
    National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Mailstop E 05, Atlanta, GA 30333, USA
    Expert Rev Vaccines 7:437-56. 2008
    ....
  2. ncbi Reflections on pandemics, past and present
    Anne Schuchat
    National Center for Immunization and Respiratory Disease, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
    Am J Obstet Gynecol 204:S4-6. 2011
    ..The roles played by the Centers for Disease Control and Prevention related to pregnancy-associated influenza during the 2009 pandemic are described. Risk communication principles are summarized and resources provided...
  3. ncbi Active bacterial core surveillance of the emerging infections program network
    A Schuchat
    Centers for Disease Control and Prevention, Mailstop C23, 1600 Clifton Rd, Atlanta, GA 30333, USA
    Emerg Infect Dis 7:92-9. 2001
    ..More information on ABCs is available at www.cdc.gov/ncidod/dbmd/abcs. ABCs specimens will soon be available to researchers through an archive...
  4. ncbi Pneumonia in children in the developing world: new challenges, new solutions
    Anne Schuchat
    Respiratory Diseases Branch, Division of Bacterial and Mycotic Diseases, National Center for Infectious Diseases, Centers for Disease Control and Prevention, 1600 Clifton Road NE, Atlanta, GA 30333, USA
    Semin Pediatr Infect Dis 15:181-9. 2004
    ..Surveillance tools are needed that will bridge studies of interventions, establish preventable disease burden, and serve as indicators for monitoring new programs...
  5. ncbi The science behind preparing and responding to pandemic influenza: the lessons and limits of science
    Anne Schuchat
    Centers for Disease Control and Prevention, Atlanta, Georgia, USA
    Clin Infect Dis 52:S8-12. 2011
    ..Many aspects of the 2009-2010 pandemic influenza experience provide ongoing opportunities for additional study, which will strengthen plans for future pandemic response as well as control of seasonal influenza...
  6. ncbi Inhalational anthrax outbreak among postal workers, Washington, D.C., 2001
    Puneet K Dewan
    Centers for Desease Control and Prevention, Atlanta, Georgia 30333, USA
    Emerg Infect Dis 8:1066-72. 2002
    ..Prophylaxis was necessary for all employees. To protect postal workers against bioterrorism, measures to reduce the risk of occupational exposure are necessary...
  7. ncbi The changing epidemiology of meningococcal disease in the United States, 1992-1996
    N E Rosenstein
    Division of Bacterial Diseases, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
    J Infect Dis 180:1894-901. 1999
    ..Ongoing surveillance is necessary to determine the stability of serogroup and serosubtype distribution...
  8. ncbi Evaluation of universal antenatal screening for group B streptococcus
    Melissa K Van Dyke
    Epidemic Intelligence Service Program, Office of Workforce and Career Development, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
    N Engl J Med 360:2626-36. 2009
    ..In 2002, national guidelines recommended universal late antenatal screening of pregnant women for colonization with group B streptococcus to identify candidates for intrapartum chemoprophylaxis...
  9. ncbi Cryptococcosis: population-based multistate active surveillance and risk factors in human immunodeficiency virus-infected persons. Cryptococcal Active Surveillance Group
    R A Hajjeh
    Centers for Disease Control and Prevention, Mycotic Diseases Branch, Division of Bacterial and Mycotic Diseases, Atlanta, GA 30333, USA
    J Infect Dis 179:449-54. 1999
    ..Further studies are needed to better describe persons with AIDS currently developing cryptococcosis in the era of highly active antiretroviral therapy...
  10. ncbi Incidence of macrolide resistance in Streptococcus pneumoniae after introduction of the pneumococcal conjugate vaccine: population-based assessment
    David S Stephens
    Department of Medicine, Emory University School of Medicine, Atlanta, GA, USA
    Lancet 365:855-63. 2005
    ..We assessed emergence of macrolide-resistant invasive S pneumoniae disease in Atlanta, GA, USA, before and after the licensing, in February 2000, of the heptavalent pneumococcal conjugate vaccine for young children...
  11. ncbi Clinical outcomes of meningitis caused by Streptococcus pneumoniae in the era of antibiotic resistance
    A E Fiore
    Respiratory Diseases Branch, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
    Clin Infect Dis 30:71-7. 2000
    ..Empirical use of vancomycin, current prevalence of drug-resistant S. pneumoniae, and degree of nonsusceptibility to cefotaxime may have influenced these findings...
  12. ncbi Multistate evaluation of invasive pneumococcal diseases in adults with human immunodeficiency virus infection: serotype and antimicrobial resistance patterns in the United States
    A M Fry
    Respiratory Diseases Branch, Division of Bacterial and Mycotic Diseases, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
    J Infect Dis 188:643-52. 2003
    ..HIV/AIDS was not an independent risk factor for TMP-SMZ nonsusceptibility. Vulnerability to certain serotypes among adults with HIV/AIDS may have implications in prevention strategies...
  13. ncbi Impact of conjugate vaccine on transmission of antimicrobial-resistant Streptococcus pneumoniae among Alaskan children
    Sarah Y Park
    From the Office of Workforce and Career Development, Centers for Disease Control and Prevention CDC, Atlanta, GA, USA
    Pediatr Infect Dis J 27:335-40. 2008
    ..The impact of heptavalent pneumococcal conjugate vaccine (PCV7) on transmission of antimicrobial-resistant Streptococcus pneumoniae is an important concern for countries considering PCV7 introduction...
  14. ncbi Streptococcus pneumoniae and Haemophilus influenzae type B Carriage, Central Asia
    Stephanie H Factor
    Centers for Disease Control and Prevention, Atlanta, Georgia, USA
    Emerg Infect Dis 11:1476-9. 2005
    ..Approximately 6% of children carried Haemophilus influenzae type b (Hib). Using pneumococcal and Hib conjugate vaccines may decrease illness in the Central Asian Republics...
  15. ncbi Epidemiology of group B streptococcal disease in the United States: shifting paradigms
    A Schuchat
    Respiratory Diseases Branch, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
    Clin Microbiol Rev 11:497-513. 1998
    ....
  16. ncbi Effect of introduction of the pneumococcal conjugate vaccine on drug-resistant Streptococcus pneumoniae
    Moe H Kyaw
    Respiratory Diseases Branch, Division of Bacterial and Mycotic Diseases, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, USA
    N Engl J Med 354:1455-63. 2006
    ..There was an increase in infections caused by serotypes not included in the vaccine...
  17. ncbi Impact of intrapartum antibiotics on the care and evaluation of the neonate
    Sharon Balter
    Respiratory Diseases Branch, Centers for Disease Control and Prevention, Atlanta, GA, USA
    Pediatr Infect Dis J 22:853-7. 2003
    ..Consistent with the guidelines, collection of complete blood counts was more common among such infants...
  18. ncbi Group B streptococcal disease in the era of intrapartum antibiotic prophylaxis
    S J Schrag
    Respiratory Diseases Branch, Division of Bacterial and Mycotic Disease, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
    N Engl J Med 342:15-20. 2000
    ..To assess the effects of the preventive efforts, we analyzed trends in the incidence of group B streptococcal disease from 1993 to 1998...
  19. ncbi Association between colonization with group B streptococci during pregnancy and preterm delivery among Danish women
    D R Feikin
    Respiratory Diseases Branch, Division of Bacterial and Mycotic Diseases, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia 30341-3724, USA
    Am J Obstet Gynecol 184:427-33. 2001
    ..CONCLUSION: Group B streptococcal colonization at delivery, but not at < or = 24 weeks' gestation, was associated with preterm delivery...
  20. ncbi Clinical outcomes of bacteremic pneumococcal pneumonia in the era of antibiotic resistance
    J F Moroney
    Respiratory Diseases Branch, Division of Bacterial and Mycotic Diseases, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
    Clin Infect Dis 33:797-805. 2001
    ..Factors other than resistance, such as severity of illness at presentation and advance directive status ("do not resuscitate" orders), appear to have a stronger influence on pneumococcal pneumonia outcomes...
  21. ncbi Prevention of neonatal sepsis
    Stephanie Schrag
    Division of Bacterial and Mycotic Diseases, National Center for Infectious Diseases, Mailstop, C-23 Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
    Clin Perinatol 32:601-15. 2005
    ..This article synthesizes information on neonatal sepsis disease burden, trends, and risk factors and reviews current and potential approaches to neonatal sepsis prevention...
  22. ncbi Impact of intrapartum chemoprophylaxis on neonatal sepsis
    Anne Schuchat
    Centers for Disease Control and Prevention, Atlanta, GA, USA
    Pediatr Infect Dis J 22:1087-8. 2003
  23. ncbi Epidemiology of invasive group a streptococcus disease in the United States, 1995-1999
    Katherine L O'Brien
    Respiratory Diseases Branch, Division of Bacterial and Mycotic Diseases, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA
    Clin Infect Dis 35:268-76. 2002
    ..We estimate that 9600-9700 cases of invasive GAS disease occur in the United States each year, resulting in 1100-1300 deaths...
  24. ncbi Trends in incidence and antimicrobial resistance of early-onset sepsis: population-based surveillance in San Francisco and Atlanta
    Terri B Hyde
    Active Bacterial Core surveillance of the Emerging Infections Program Network, Division of Bacterial and Mycotic Diseases, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
    Pediatrics 110:690-5. 2002
    ..Overall, these trends are reassuring, but careful evaluation of the increase in resistant infections in very young infants is critical in the future...
  25. ncbi Evaluation of effectiveness of the 23-valent pneumococcal capsular polysaccharide vaccine for HIV-infected patients
    R F Breiman
    Centers for Disease Control and Prevention, 1600 Clifton Rd, MS C 12, Atlanta, GA 30333, USA
    Arch Intern Med 160:2633-8. 2000
    ..We conducted a retrospective case-control study to evaluate effectiveness of pneumococcal vaccine against invasive disease among adults with human immunodeficiency virus (HIV) infection in San Francisco, Calif, and Atlanta, Ga...
  26. ncbi Age-dependent Neisseria meningitidis serogroup C class-specific antibody concentrations and bactericidal titers in sera from young children from Montana immunized with a licensed polysaccharide vaccine
    S E Maslanka
    Division of Bacterial and Mycotic Diseases, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
    Infect Immun 66:2453-9. 1998
    ..The bactericidal results show age-dependent differences in the production and retention of antibody in young children immunized with serogroup C polysaccharide; these differences are not evident with the ELISA data...
  27. ncbi Management of community-acquired pneumonia in the era of pneumococcal resistance: a report from the Drug-Resistant Streptococcus pneumoniae Therapeutic Working Group
    J D Heffelfinger
    Respiratory Diseases Branch, Centers for Disease Control and Prevention, Atlanta, GA, USA
    Arch Intern Med 160:1399-408. 2000
    ..To provide recommendations for the management of community-acquired pneumonia and the surveillance of drug-resistant Streptococcus pneumoniae (DRSP)...
  28. ncbi Epidemiology of pneumococcal infections in the elderly
    J C Butler
    Arctic Investigations Program, National Center for Infectious Diseases, CDC, Anchorage, Alaska 99508, USA
    Drugs Aging 15:11-9. 1999
    ....
  29. ncbi Increased prevalence of pediatric pneumococcal serotypes in elderly adults
    Daniel R Feikin
    Division of Bacterial and Mycotic Diseases, National Center for Infectious Disease, Centers for Disease Control and Prevention, Atlanta, Georgia, USA
    Clin Infect Dis 41:481-7. 2005
    ..CONCLUSIONS: The increased proportion of severe pneumococcal disease caused by pediatric serotypes in the elderly population might indicate opportunities for prevention with use of PCV7...
  30. ncbi Opportunities for prevention of perinatal group B streptococcal disease: a multistate surveillance analysis. The Neonatal Group B Streptococcal Disease Study Group
    N E Rosenstein
    Centers for Disease Control and Prevention, Atlanta, Georgia, USA
    Obstet Gynecol 90:901-6. 1997
    ..To evaluate the potential impact of ACOG and Centers for Disease Control and Prevention (CDC) consensus strategies for the prevention of perinatal group B streptococcal disease...
  31. ncbi Supporting new vaccine introduction decisions: lessons learned from the Hib Initiative experience
    R A Hajjeh
    Division of Bacterial Diseases, Centers for Disease Control and Prevention, 1600 Clifton Road NE, MS C 25, Atlanta, GA 30333, USA
    Vaccine 28:7123-9. 2010
    ..This paper reviews the strategy adopted by the Hib Initiative and the lessons learned in the process, which provide a useful model to accelerate uptake of other new vaccines...
  32. ncbi Group B streptococcal disease prevention practices of obstetrician-gynecologists
    J P Watt
    Respiratory Diseases Branch, Division of Bacterial and Mycotic Diseases, National Center for Infectious Disease, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
    Obstet Gynecol 98:7-13. 2001
    ..To describe group B streptococcal (GBS) disease prevention practices of obstetrician-gynecologists...
  33. ncbi Adverse and beneficial secondary effects of mass treatment with azithromycin to eliminate blindness due to trachoma in Nepal
    A M Fry
    Respiratory Diseases Branch, Division of Bacterial and Mycotic Diseases, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
    Clin Infect Dis 35:395-402. 2002
    ....
  34. ncbi Group B streptococcal disease: from trials and tribulations to triumph and trepidation
    A Schuchat
    Respiratory Diseases Branch, Division of Bacterial and Mycotic Diseases, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
    Clin Infect Dis 33:751-6. 2001
    ..This recent triumph leaves the professional community treading lightly, alert to the need to monitor for unintended consequences that may threaten recent progress...
  35. ncbi Trends in sepsis-related neonatal mortality in the United States, 1985-1998
    Susan L Lukacs
    National Center for Health Statistics, Centers for Disease Control and Prevention, Hyattsville, MD 20782, USA
    Pediatr Infect Dis J 23:599-603. 2004
    ..To understand the influence of IAP on neonatal sepsis, in general, we evaluated neonatal mortality from sepsis before and after IAP recommendations were issued...
  36. ncbi Global strategies to prevent bacterial pneumonia in adults with HIV disease
    Daniel R Feikin
    Respiratory Diseases Branch, Division of Bacterial and Mycotic Diseases, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA
    Lancet Infect Dis 4:445-55. 2004
    ..Although not yet fully evaluated in Africa, based on experience in industrialised nations, use of HAART in Africa may have substantial potential to prevent bacterial pneumonia...
  37. ncbi Opportunities to reduce overuse of antibiotics for perinatal group B streptococcal disease prevention and management of preterm premature rupture of membranes
    Nina E Glass
    Division of Bacterial and Mycotic Diseases, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta 30333, USA
    Infect Dis Obstet Gynecol 13:5-10. 2005
    ..1 to 3.4) were associated with prescribing prolonged antibiotics for pPROM. CONCLUSION: Prenatal antibiotic treatment for GBS colonization and prolonged antibiotic treatment for pPROM contribute to overuse of antibiotics in obstetrics...
  38. ncbi Impact of a conjugate vaccine on community-wide carriage of nonsusceptible Streptococcus pneumoniae in Alaska
    Matthew R Moore
    Division of Applied Public Health Training, Epidemiology Program Office, National Center for Infectious Diseases, Centers for Disease Control and Prevention, 1600 Clifton Road NE, Atlanta, GA 30333, USA
    J Infect Dis 190:2031-8. 2004
    ..Antimicrobial resistance among pneumococci has increased in recent years and complicates treatment. The introduction of heptavalent pneumococcal conjugate vaccine (PCV7) could reduce acquisition of antimicrobial-resistant pneumococci...
  39. ncbi Impact of heptavalent pneumococcal conjugate vaccine on invasive disease, antimicrobial resistance and colonization in Alaska Natives: progress towards elimination of a health disparity
    Thomas W Hennessy
    Arctic Investigations Program, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Anchorage, AK 99508, USA
    Vaccine 23:5464-73. 2005
    ..001 each). PCV7 vaccine has eliminated a longstanding disparity of vaccine-type IPD for AN children. Decreased vaccine-type colonization and IPD in adults demonstrate indirect vaccine effects...
  40. ncbi Prevention of invasive pneumococcal disease among HIV-infected adults in the era of childhood pneumococcal immunization
    Adam L Cohen
    Respiratory Diseases Branch, Division of Bacterial Diseases, USA
    AIDS 24:2253-62. 2010
    ..We evaluated IPD among HIV-infected adults over a 10-year period in the US to identify opportunities for prevention of IPD among HIV-infected adults...
  41. ncbi Effectiveness of 23-valent polysaccharide pneumococcal vaccine on pneumonia in HIV-infected adults in the United States, 1998--2003
    Eyasu H Teshale
    Centers for Disease Control and Prevention, National Center for HIV, Hepatitis, STD, and TB Prevention, Division of HIV AIDS Prevention, Atlanta, GA, USA
    Vaccine 26:5830-4. 2008
    ..However, PPV-23 provided no benefit when patients were vaccinated at HIV viral load > 100,000 copies/ml, irrespective of CD4 count at vaccination. Receipt of PPV-23 was associated with lower incidence of all-cause pneumonia...
  42. ncbi Effectiveness of seven-valent pneumococcal conjugate vaccine against invasive pneumococcal disease: a matched case-control study
    Cynthia G Whitney
    Division of Bacterial and Mycotic Diseases, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA
    Lancet 368:1495-502. 2006
    ..Our aim was to assess the effectiveness of the vaccine against various pneumococcal serotypes, and to measure the effectiveness of the recommended dose schedule and of catch-up and incomplete schedules...
  43. ncbi Delivering pneumococcal vaccine to a high risk population: the Navajo experience
    Andrea L Benin
    Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
    Hum Vaccin 1:66-9. 2005
    ....
  44. ncbi Adults with invasive pneumococcal disease: missed opportunities for vaccination
    Moe H Kyaw
    Respiratory Diseases Branch, Division of Bacterial and Mycotic Diseases, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
    Am J Prev Med 31:286-92. 2006
    ..Missed opportunities for vaccination were defined as one or more visits to a hospital, emergency room (ER), or main provider in the 2 years before infection among unvaccinated, adult IPD case-patients with a vaccine indication...
  45. ncbi Early experience with human papillomavirus vaccine introduction in the United States, Canada and Australia
    Abigail Shefer
    National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA
    Vaccine 26:K68-75. 2008
    ..It focuses on the United States of America and Canada and provides a brief report on Australia, where introduction is underway...
  46. ncbi Risk factors for invasive, early-onset Escherichia coli infections in the era of widespread intrapartum antibiotic use
    Stephanie J Schrag
    Division of Bacterial and Mycotic Diseases, National Center for Infectious Diseases, Atlanta, Georgia, USA
    Pediatrics 118:570-6. 2006
    ..The goal was to evaluate risk factors for invasive Escherichia coli infections in the first week of life (early onset), focusing on the role of intrapartum antibiotic use...
  47. ncbi Risk factors for invasive pneumococcal disease in children in the era of conjugate vaccine use
    Tamar Pilishvili
    Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
    Pediatrics 126:e9-17. 2010
    ..We conducted a case-control study to evaluate risk factors for invasive pneumococcal disease (IPD) among children who were aged 3 to 59 months in the era of pneumococcal conjugate vaccine (PCV7)...
  48. ncbi Changes in invasive Pneumococcal disease among HIV-infected adults living in the era of childhood pneumococcal immunization
    Brendan Flannery
    National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
    Ann Intern Med 144:1-9. 2006
    ..Adults infected with HIV have high rates of invasive pneumococcal disease. Introduction of pneumococcal conjugate vaccine for children could affect disease among HIV-infected adults...
  49. ncbi Epidemiology of invasive group B streptococcal disease in the United States, 1999-2005
    Christina R Phares
    Epidemic Intelligence Service Program, Office of Workforce and Career Development, Division of Bacterial Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
    JAMA 299:2056-65. 2008
    ..Guidelines for prevention of perinatal disease through intrapartum chemoprophylaxis were revised in 2002. Candidate vaccines are under development...
  50. ncbi Prenatal screening for infectious diseases and opportunities for prevention
    Stephanie J Schrag
    Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
    Obstet Gynecol 102:753-60. 2003
    ..To characterize adherence with recommendations for prenatal infectious disease screening and missed opportunities for prevention of congenital and perinatal infections...
  51. ncbi Sentinel surveillance: a reliable way to track antibiotic resistance in communities?
    Stephanie J Schrag
    Respiratory Diseases Branch, Division of Bacterial and Mycotic Diseases, Centers for Disease Control and Prevention, 1600 Clifton Road, Atlanta, GA 30333, USA
    Emerg Infect Dis 8:496-502. 2002
    ..Sentinel surveillance for resistant pneumococci can detect important trends over time but rarely detects newly emerging resistance profiles...
  52. ncbi Vaccination and perinatal infection prevention practices among obstetrician-gynecologists
    Stephanie J Schrag
    National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, 30333, USA
    Obstet Gynecol 101:704-10. 2003
    ..To assist efforts to improve adult vaccination coverage by characterizing vaccination and infectious disease screening practices of obstetrician-gynecologists...
  53. ncbi Effects of intrapartum antimicrobial prophylaxis for prevention of group-B-streptococcal disease on the incidence and ecology of early-onset neonatal sepsis
    Matthew R Moore
    Epidemic Intelligence Service Program, Division of Applied Public Health Training, Epidemiology Program Office, Centers for Disease Control and Prevention, Atlanta, GA, USA
    Lancet Infect Dis 3:201-13. 2003
    ..We propose systematic monitoring of early-onset sepsis, coupled with targeted research, to inform periodic reassessment of prevention strategies...
  54. ncbi An outbreak of conjunctivitis due to atypical Streptococcus pneumoniae
    Michael Martin
    Respiratory Diseases Branch, Division of Bacterial and Mycotic Diseases, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
    N Engl J Med 348:1112-21. 2003
    ..CONCLUSIONS: This large outbreak of conjunctivitis on a college campus was caused by an atypical, unencapsulated strain of S. pneumoniae that was identical to strains that had caused outbreaks two decades earlier...
  55. ncbi Adherence to antimicrobial inhalational anthrax prophylaxis among postal workers, Washington, D.C., 2001
    Mariaelena D Jefferds
    Centers for Desease Control and Prevention, Atlanta, Georgia 30333, USA
    Emerg Infect Dis 8:1138-44. 2002
    ..Interventions, especially frequent visits by public health staff, proved effective in supporting adherence...
  56. ncbi Specific, sensitive, and quantitative enzyme-linked immunosorbent assay for human immunoglobulin G antibodies to anthrax toxin protective antigen
    Conrad P Quinn
    Centers for Desease Control and Prevention, Atlanta, Georgia 30333, USA
    Emerg Infect Dis 8:1103-10. 2002
    ..The anti-PA ELISAs proved valuable for the confirmation of cases of cutaneous and inhalational anthrax and evaluation of patients in whom the diagnosis of anthrax was being considered...
  57. ncbi Opening a bacillus anthracis-containing envelope, Capitol Hill, Washington, D.C.: the public health response
    Vincent P Hsu
    Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
    Emerg Infect Dis 8:1039-43. 2002
    ..Early nasal swab testing is a useful epidemiologic tool to assess risk of exposure to aerosolized B. anthracis. Early, wide chemoprophylaxis may have averted an outbreak of anthrax in this population...
  58. ncbi Investigation of bioterrorism-related anthrax, United States, 2001: epidemiologic findings
    Daniel B Jernigan
    Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
    Emerg Infect Dis 8:1019-28. 2002
    ..Continued vigilance for cases is needed among health-care providers and members of the public health and law enforcement communities...
  59. ncbi Population-based surveillance for postpartum invasive group a streptococcus infections, 1995-2000
    Ilin Chuang
    Respiratory Diseases Branch, Division of Bacterial and Mycotic Diseases, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA, 30333, USA
    Clin Infect Dis 35:665-70. 2002
    ..Although postpartum GAS infections are rare, the clustering of infections due to identical strains suggests that some invasive cases may have a common source and, therefore, may be preventable...
  60. ncbi A population-based comparison of strategies to prevent early-onset group B streptococcal disease in neonates
    Stephanie J Schrag
    Respiratory Diseases Branch, MS C23, Division of Bacterial and Mycotic Disease, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
    N Engl J Med 347:233-9. 2002
    ....
  61. ncbi Integrated monitoring of a new group B streptococcal disease prevention program and other perinatal infections
    Anne Schuchat
    Division of Bacterial and Mycotic Diseases, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
    Matern Child Health J 6:107-14. 2002
    ..To determine levels of prenatal screening for several infections, intrapartum recognition of risk factors, and prophylaxis against mother-to-child transmission of group B streptococcus...
  62. ncbi Public health issues related to infection in pregnancy and cerebral palsy
    Diana E Schendel
    Division of Birth Defects and Developmental Disabilities, National Center on Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention, Atlanta, Georgia 30341, USA
    Ment Retard Dev Disabil Res Rev 8:39-45. 2002
    ..Given the gaps in our current knowledge about intrauterine infection and cerebral palsy, public health recommendations for timely and specific prevention activities are limited at this time...
  63. ncbi Classical and latent class analysis evaluation of sputum polymerase chain reaction and urine antigen testing for diagnosis of pneumococcal pneumonia in adults
    Jay C Butler
    Respiratory Diseases Branch, Division of Bacterial and Mycotic Diseases, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA
    J Infect Dis 187:1416-23. 2003
    ..LCA may be useful for diagnostic test evaluation and for determining the prevalence of pneumococcal infection in epidemiological studies of community-acquired pneumonia and in vaccine efficacy trials...
  64. ncbi Disease surveillance and the academic, clinical, and public health communities
    Robert W Pinner
    Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
    Emerg Infect Dis 9:781-7. 2003
    ....
  65. ncbi Invasive group A streptococcal disease: risk factors for adults
    Stephanie H Factor
    Centers for Disease Control and Prevention, Atlanta, Georgia, USA
    Emerg Infect Dis 9:970-7. 2003
    ..68, p=0.004), diabetes (RR=2.27, p=0.03), cardiac disease (RR=3.24, p=0.006), cancer (RR=3.54, p=0.006), and corticosteroid use (RR=5.18, p=0.03). Thus, host and environmental factors increased the risk for invasive GAS disease...
  66. ncbi Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine
    Cynthia G Whitney
    Division of Bacterial and Mycotic Diseases, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
    N Engl J Med 348:1737-46. 2003
    ..In early 2000, a protein-polysaccharide conjugate vaccine targeting seven pneumococcal serotypes was licensed in the United States for use in young children...
  67. ncbi Seasonal patterns of invasive pneumococcal disease
    Scott F Dowell
    International Emerging Infections Program, Department of Medical Sciences, Ministry of Public Health, Building 2, Tivanon Road, Nonthaburi 11000, Bangkok, Thailand
    Emerg Infect Dis 9:573-9. 2003
    ....
  68. ncbi Report from the CDC. Awareness of perinatal group B streptococcal infection among women of childbearing age in the United States, 1999 and 2002
    Karen Cowgill
    Respiratory Diseases Branch, Division of Bacterial and Mycotic Diseases, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA
    J Womens Health (Larchmt) 12:527-32. 2003
    ....
  69. ncbi Effectiveness of the 23-valent polysaccharide vaccine against invasive pneumococcal disease in Navajo adults
    Andrea L Benin
    Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
    J Infect Dis 188:81-9. 2003
    ..PPV23 was not significantly effective among Navajo adults and may be inadequate to prevent serious pneumococcal disease in this population...
  70. ncbi Surveillance for meningococcal disease and strategies for use of conjugate meningococcal vaccines in the United States
    J R Lingappa
    Centers for Disease Control and Prevention, Mailstop C 09, 1600 Clifton Road, NE, Atlanta, GA 30333, USA
    Vaccine 19:4566-75. 2001
    ..We evaluated the relative burdens of invasive meningococcal disease in US and examined the projected impact of various meningococcal conjugate vaccination strategies on rates of meningococcal disease...
  71. ncbi The emergence of Streptococcus pneumoniae resistant to macrolide antimicrobial agents: a 6-year population-based assessment
    K Gay
    Departments of Medicine and of Microbiology and Immunology, Emory University School of Medicine, Atlanta, Georgia, USA
    J Infect Dis 182:1417-24. 2000
    ..Dissemination of the mefE determinant accounted for the rapid increase in the rate of macrolide resistance in our S. pneumoniae population...
  72. ncbi Risk factors for pediatric invasive group A streptococcal disease
    Stephanie H Factor
    Centers for Disease Control and Prevention, Atlanta, Georgia, USA
    Emerg Infect Dis 11:1062-6. 2005
    ..67, p=0.03) and household member(s) with runny nose (OR=0.09, p=0.002) were associated with decreased risk. Among children, household-level characteristics that influence exposure to GAS most affect development of invasive disease...
  73. ncbi Comparing potential benefits of new pneumococcal vaccines with the current polysaccharide vaccine in the elderly
    Alicia M Fry
    Respiratory Diseases Branch, Center for Disease Control and Prevention, Mailstop C-23, 1600 Clifton Road, NE, Atlanta, GA 30333, USA
    Vaccine 21:303-11. 2002
    ..Superior effectiveness of new vaccines was dependent upon a presumed longer duration of protection than the 23V-PPV and effectiveness against noninvasive pneumonia. Our results suggest that new vaccines could improve disease prevention...
  74. ncbi Socioeconomic and racial/ethnic disparities in the incidence of bacteremic pneumonia among US adults
    Deron C Burton
    Respiratory Diseases Branch, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
    Am J Public Health 100:1904-11. 2010
    ..We examined associations between the socioeconomic characteristics of census tracts and racial/ethnic disparities in the incidence of bacteremic community-acquired pneumonia among US adults...
  75. ncbi Epidemiology of invasive Streptococcus pneumoniae infections in the United States, 1995-1998: Opportunities for prevention in the conjugate vaccine era
    K A Robinson
    Respiratory Diseases Branch, Division of Bacterial and Mycotic Diseases, National Center for Infectious Diseases, Centers for Disease Control and Prevention, MS D 65, 1600 Clifton Rd NE, Atlanta, GA 30333, USA
    JAMA 285:1729-35. 2001
    ..Additionally, a recently licensed pneumococcal 7-valent conjugate vaccine has been recommended for use in young children and could dramatically change the epidemiology of pneumococcal disease...
  76. ncbi Group B streptococcus
    A Schuchat
    Respiratory Disease Branch, Division of Bacterial and Mycotic Diseases, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
    Lancet 353:51-6. 1999
    ..Finally, the pathogen itself has continued to evolve: new capsular serotypes described in the past decade are now causing an important proportion of clinical infections...
  77. ncbi Association between antimicrobial resistance among pneumococcal isolates and burden of invasive pneumococcal disease in the community
    Julia Y Morita
    Division of Bacterial and Mycotic Diseases, National Centers for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA
    Clin Infect Dis 35:420-7. 2002
    ..The proportion of multidrug-resistant pneumococcal isolates did not predict invasive cases among adults. The increasing prevalence of multidrug-resistant pneumococci among children may be leading to an increase in invasive disease...
  78. ncbi Invasive group-A streptococcal infection in an allograft recipient. A case report
    Ellen H Lee
    Epidemic Intelligence Service, Career Development Division, Office of Workforce and Career Development, Centers for Disease Control and Prevention, 1600 Clifton Road, Atlanta, GA 30333, USA
    J Bone Joint Surg Am 89:2044-7. 2007
  79. ncbi Toxic shock syndrome in the United States: surveillance update, 1979 1996
    R A Hajjeh
    Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
    Emerg Infect Dis 5:807-10. 1999
    ..We reviewed surveillance data for the period 1979 to 1996, when 5,296 cases were reported, and discuss changes in the epidemiologic features of TSS...
  80. ncbi Epidemic nephritis in Nova Serrana, Brazil
    S Balter
    Respiratory Diseases Branch, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
    Lancet 355:1776-80. 2000
    ..From December, 1997, to July, 1998, 253 cases of acute nephritis were identified in Nova Serrana, Brazil. Seven patients required dialysis, and three patients died. We did a case-control study to investigate the cause of the outbreak...
  81. ncbi Infections in international pregnancy study: performance of the optical immunoassay test for detection of group B streptococcus
    Jadsada Thinkhamrop
    Department of Obstetrics and Gynecology, Faculty of Medicine, Khon Kaen University, Khon Kaen, Bangkok, Thailand
    J Clin Microbiol 41:5288-90. 2003
    ..Compared to culture, the sensitivity and specificity of OIA were 13.3 and 98.4%, respectively, for light colonization and 41.5 and 97.7%, respectively, for heavy colonization...
  82. ncbi Prevention of influenza: recommendations for influenza immunization of children, 2007-2008
    Joseph A Bocchini
    Pediatrics 121:e1016-31. 2008
    ..However, oseltamivir and zanamivir can be prescribed for treatment or chemoprophylaxis, because influenza A and B strains remain susceptible...
  83. ncbi Serotype distribution and antibiotic susceptibility of invasive and nasopharyngeal isolates of Streptococcus pneumoniae among children in rural Mozambique
    Xavier Valles
    Centre de Salut Internacional Hospital Clínic IDIBAPS, Barcelona, Spain
    Trop Med Int Health 11:358-66. 2006
    ..To describe and compare serotype distribution and antibiotic susceptibility of invasive and nasopharyngeal isolates of Streptococcus pneumoniae from children in rural Mozambique...
  84. ncbi Declining incidence of invasive Streptococcus pneumoniae infections among persons with AIDS in an era of highly active antiretroviral therapy, 1995-2000
    Richard T Heffernan
    Yale University School of Medicine, Department of Epidemiology and Public Health, New Haven, Connecticut, USA
    J Infect Dis 191:2038-45. 2005
    ..Our goal was to describe trends in invasive pneumococcal disease incidence among persons with acquired immunodeficiency syndrome (AIDS) since the introduction of highly active antiretroviral therapy (HAART)...
  85. ncbi Easing the burden: characterizing the disease burden of neonatal group B streptococcal disease to motivate prevention
    Stephanie J Schrag
    Clin Infect Dis 38:1209-11. 2004
  86. ncbi Perinatal infections due to group B streptococci
    Ronald S Gibbs
    Department of Obstetrics and Gynecology, University of Colorado School of Medicine, Denver, Colorado 80262, USA
    Obstet Gynecol 104:1062-76. 2004
    ....
  87. ncbi Perinatal group B streptococcal disease prevention, Minnesota
    Craig A Morin
    Minnesota Department of Health, Minneapolis, Minnesota 55414, USA
    Emerg Infect Dis 11:1467-9. 2005
    ..In 2002, all Minnesota providers surveyed reported using a prevention policy. Most screen vaginal and rectal specimens at 34-37 weeks of gestation. The use of screening-based methods has increased dramatically since 1998...
  88. ncbi Barriers to implementing the group B streptococcal prevention guidelines
    Vicky Cardenas
    Department of Epidemiology at the University of Washington, Seattle, Washington 98195, USA
    Birth 29:285-90. 2002
    ..We assessed predictors of compliance with the consensus guidelines for perinatal group B streptococcus disease prevention at two Group Health Cooperative hospitals...
  89. ncbi Prevention of perinatal group B streptococcal disease. Revised guidelines from CDC
    Stephanie Schrag
    MMWR Recomm Rep 51:1-22. 2002
    ....
  90. ncbi Severe acute respiratory syndrome, Beijing, 2003
    Wannian Liang
    Beijing Municipal Health Bureau and Beijing Municipal Centers for Disease Prevention and Control, Beijing, China
    Emerg Infect Dis 10:25-31. 2004
    ..Implementation of early detection, isolation, contact tracing, quarantine, triage of case-patients to designated SARS hospitals, and community mobilization ended the outbreak...
  91. ncbi From pandemic suspect to the postvaccine era: the Haemophilus influenzae story
    Anne Schuchat
    Clin Infect Dis 44:817-9. 2007
  92. ncbi Perinatal group B streptococcal disease
    Paul T Heath
    Vaccine Institute and Division of Child Health, St George s, University of London, London SW17 0RE, UK
    Best Pract Res Clin Obstet Gynaecol 21:411-24. 2007
    ..Decisions on which strategy to use will depend on a number of factors. A swab-based approach appears to have higher efficacy but is likely to lead to more antibiotic exposure...
  93. ncbi Risk factors for invasive pneumococcal disease among Navajo adults
    James P Watt
    Center for American Indian Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD 21205, USA
    Am J Epidemiol 166:1080-7. 2007
    ..The high prevalence of renal failure, alcoholism, and unemployment among Navajo adults compared with the general US population may explain some of their increased risk of IPD...
  94. ncbi Risk factors for SARS among persons without known contact with SARS patients, Beijing, China
    Jiang Wu
    Beijing Center for Disease Prevention and Control, Beijing, China
    Emerg Infect Dis 10:210-6. 2004
    ..Our finding that mask use lowered the risk for disease supports the community's use of this strategy...